US Edition
News from Pharmaceutical Business review
Information about Pharmaceutical Business Review
Where is Pharmaceutical Business Review located?Pharmaceutical Business Review's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pharmaceutical Business Review News
Cancer · CambridgeInsilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and developing innovative oncology therapies, by combining Insilico's AI-driven drug discovery platforms with Servier's global expertise in cancer drug development. Under the terms…See the Story
Insilico Medicine Announce US$888 Million Multi-Year Collaboration with Servier for Drug Discovery and Development in Oncology
66% Center coverage: 29 sources
United States · United StatesThe U.S. Food and Drug Administration (FDA) has approve […] The post FDA Approves 2-Gram Formulation of Fibryga for Acquired Fibrinogen Deficiency Treatment first appeared on GeneOnline News. The post FDA Approves 2-Gram Formulation of Fibryga for Acquired Fibrinogen Deficiency Treatment appeared first on GeneOnline News.See the Story
FDA Approves 2-Gram Formulation of Fibryga for Acquired Fibrinogen Deficiency Treatment
United States · United StatesCK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options.See the Story
